D-0829-2020 Class III Terminated

Recalled by UNICHEM PHARMACEUTICALS USA INC — East Brunswick, NJ

FDA drug recall D-0829-2020 was initiated by UNICHEM PHARMACEUTICALS USA INC on Jan 29, 2020 and is designated Class III. Reason for recall: Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label. The recall status is terminated (terminated Jan 8, 2021). Affected quantity: 19161600 units.

Recall details

Product Type
Drugs
Report Date
Feb 12, 2020
Initiation Date
Jan 29, 2020
Termination Date
Jan 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
19161600 units

Product description

Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufactured by: Unichem Laboratories Ltd. Pilerne Ind. Estate, Pilerne Bardez, Goa 403 511 India. Manufactured for: Unichem Pharmaceuticals (USA), Inc. East Brunswick, NJ 08816. NDC 29300-135-01

Reason for recall

Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure due to potential migration of Benzophenone at very low level into product from container label.

Distribution pattern

Distributed Nationwide in the US

Code information

Lot Numbers: GCLL18108, GCLL18109, GCLL18110 - EXP 10/31/2020; GCLL19003 EXP 12/31/2020

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0829-2020
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0829-2020. Report a data issue: hello@regdatalab.com.